This study demonstrates that the combination of AS-TMP regulates the expression and ratio of MMP-9 and TIMP-1 and modulates the HIF-VEGF signaling pathway, thereby exerting a synergistic therapeutic effect of protecting the integrity of the blood–brain barrier and alleviating ischemic injury caused by stroke. Here, TIMP1 is linked to stroke disorder.